Nau H - Search Results

1

Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.

Lampen A, Göttlicher M, Nau H. Lampen A, et al. Among authors: nau h. ALTEX. 2001;18(2):123-6. ALTEX. 2001. PMID: 11378687

2

Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.

Lampen A, Grimaldi PA, Nau H. Lampen A, et al. Among authors: nau h. Mol Pharmacol. 2005 Jul;68(1):193-203. doi: 10.1124/mol.104.009340. Epub 2005 Apr 13. Mol Pharmacol. 2005. PMID: 15829700

3

Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives.

Lampen A, Carlberg C, Nau H. Lampen A, et al. Among authors: nau h. Eur J Pharmacol. 2001 Nov 9;431(1):25-33. doi: 10.1016/s0014-2999(01)01423-6. Eur J Pharmacol. 2001. PMID: 11716839

4

New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).

Lampen A, Siehler S, Ellerbeck U, Göttlicher M, Nau H. Lampen A, et al. Among authors: nau h. Toxicol Appl Pharmacol. 1999 Nov 1;160(3):238-49. doi: 10.1006/taap.1999.8770. Toxicol Appl Pharmacol. 1999. PMID: 10544058

5

Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells.

Lampen A, Zimnik S, Nau H. Lampen A, et al. Among authors: nau h. Toxicol Appl Pharmacol. 2003 Apr 1;188(1):14-23. doi: 10.1016/s0041-008x(03)00014-0. Toxicol Appl Pharmacol. 2003. PMID: 12668118

6

S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.

Eikel D, Hoffmann K, Zoll K, Lampen A, Nau H. Eikel D, et al. Among authors: nau h. Drug Metab Dispos. 2006 Apr;34(4):612-20. doi: 10.1124/dmd.105.008078. Epub 2006 Jan 13. Drug Metab Dispos. 2006. PMID: 16415118

7

Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.

Eikel D, Lampen A, Nau H. Eikel D, et al. Among authors: nau h. Chem Res Toxicol. 2006 Feb;19(2):272-8. doi: 10.1021/tx0502241. Chem Res Toxicol. 2006. PMID: 16485903

8

Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes.

Lampen A, Meyer S, Arnhold T, Nau H. Lampen A, et al. Among authors: nau h. J Pharmacol Exp Ther. 2000 Dec;295(3):979-85. J Pharmacol Exp Ther. 2000. PMID: 11082432

9

Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells.

Lampen A, Meyer S, Nau H. Lampen A, et al. Among authors: nau h. Drug Metab Dispos. 2001 May;29(5):742-7. Drug Metab Dispos. 2001. PMID: 11302942

10

Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives.

Werling U, Siehler S, Litfin M, Nau H, Göttlicher M. Werling U, et al. Among authors: nau h. Mol Pharmacol. 2001 May;59(5):1269-76. doi: 10.1124/mol.59.5.1269. Mol Pharmacol. 2001. PMID: 11306712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters